We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-10.03%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.87B
AUM Growth
-$850M
Cap. Flow
-$474M
Cap. Flow %
-25.38%
Top 10 Hldgs %
35.79%
Holding
428
New
80
Increased
61
Reduced
58
Closed
70

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$45.9M
2
HES
Hess
HES
+$39.1M
3
LEN icon
Lennar Class A
LEN
+$23.6M
4
ERO icon
Ero Copper
ERO
+$21.2M
5
GCTS
GCT Semiconductor Holding
GCTS
+$19.8M

Top Sells

Rank Stock Value
1
FE icon
FirstEnergy
FE
+$93.6M
2
HLF icon
Herbalife
HLF
+$42.6M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$39.1M
4
ADNT icon
Adient
ADNT
+$30.4M
5
AMZN icon
Amazon
AMZN
+$26.7M

Sector Composition

Rank Sector Weight
1 Financials 26.8%
2 Healthcare 19.15%
3 Consumer Discretionary 8.96%
4 Communication Services 8.58%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APMIW
276
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
$150K 0.01%
333,332
LHDX
277
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$149K 0.01%
41,629
GIACW
278
DELISTED
Gesher I Acquisition Corp. Warrants
GIACW
$146K 0.01%
450,000
BIOR
279
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$144K 0.01%
496
SRSAW
280
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$144K 0.01%
400,000
RKTA.WS
281
DELISTED
Rocket Internet Growth Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RKTA.WS
$143K 0.01%
375,000
ADVM
282
DELISTED
Adverum Biotechnologies
ADVM
$131K 0.01%
10,000
RYM
283
RYTHM Inc
RYM
$49M
$123K 0.01%
9
BROGW
284
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$122K 0.01%
321,684
ARGUW
285
DELISTED
Argus Capital Corp. Warrant
ARGUW
$118K 0.01%
250,000
NOGNW
286
DELISTED
Nogin, Inc. Warrant
NOGNW
$100K 0.01%
400,000
OBIO icon
287
Orchestra BioMed
OBIO
$254M
$99K 0.01%
10,000
AEON icon
288
AEON Biopharma
AEON
$13.5M
$98K 0.01%
139
DRAYW
289
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$97K 0.01%
333,333
BBLN.WS
290
DELISTED
Babylon Holdings Limited Warrants, each exercisable for one Class A Ordinary Share
BBLN.WS
$90K ﹤0.01%
167,500
ORIAW
291
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$89K ﹤0.01%
239,800
GIWWW
292
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$86K ﹤0.01%
240,000
RRAC.WS
293
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$70K ﹤0.01%
175,000
+150,000
+600% +$66.8K
TRAQ.WS
294
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$70K ﹤0.01%
250,000
+175,000
+233% +$75.6K
NETC.WS
295
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$67K ﹤0.01%
+175,000
New +$76.3K
ZINGW
296
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$67K ﹤0.01%
+175,000
New +$79.9K
TSHA icon
297
Taysha Gene Therapies
TSHA
$1.89B
$65K ﹤0.01%
10,000
NKGNW
298
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$61K ﹤0.01%
100,000
ENERR
299
DELISTED
Accretion Acquisition Corp Right
ENERR
$60K ﹤0.01%
375,000
GMFIW
300
DELISTED
Aetherium Acquisition Corp Warrant
GMFIW
$56K ﹤0.01%
+400,000
New +$61.4K

Similar funds

683 Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, 683 Capital Management held 428 positions worth $1.87B, down 31% from $2.72B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

683 Capital Management withdrew a net $474M in Q1 2022, closing 70 positions and reducing 58 holdings. Its most notable exit was Adient, an estimated $30.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in Hess worth $44.2M.

  • 683 Capital Management's largest Q1 2022 buy was Hess: 412,500 shares worth $44.2M.
  • 683 Capital Management added most to Carvana in Q1 2022, an estimated $45.9M increase.
  • 683 Capital Management's biggest Q1 2022 reduction was FirstEnergy, cutting an estimated $93.6M.
  • 683 Capital Management fully exited Adient in Q1 2022, selling an estimated $30.4M.
  • 683 Capital Management's ten largest holdings make up 36% of its $1.87B portfolio in Q1 2022.
  • 683 Capital Management opened 80 new positions and closed 70 in Q1 2022.
  • 683 Capital Management's portfolio value fell 31% quarter-over-quarter to $1.87B.

Based on 683 Capital Management's 13F filing for Q1 2022, filed 16 May 2022.